[Adrenergic receptors in the liver parenchyma in children with chronic hepatitis].
In the present study adrenergic receptors have been investigated in liver parenchyma, obtained at the resection of extrahepatic portal hypertension children without parenchymal affection (control group, n-7) and the resection of children in parenchymal affection (group of chronic hepatitis children, n-6). It has been shown, that the binding of beta-adrenergic radioligand 3H-dihydroalprenolol (3H-DHA) in liver parenchyma membranes of both control and chronic hepatitis groups was saturable and showed high affinity. The Scatchard analysis of the binding data indicated that the binding site was characterized by Kd and Bmax of 1.2 +/- 0.5 nM, 261.2 +/- 50 fmol/mg, respectively, for the control group; and 0.9 +/- 0.15 nM, 68.5 +/- 18.8 fmol/mg, respectively, for the group of chronic hepatitis patients; (mean+SEM). The binding of alpha 1-adrenergic antagonist 3H-prazosin (3H-PRZ) in liver parenchyma was also saturable and showed high affinity. The binding site is characterized by Kd = 0.6 +/- 0.12 nM, Bmax = 92.8 +/- 8.0 fmol/mg, for the control group; and Kd = 0.8 +/- 0.15 nM, Bmax = 195.0 +/- 22.0 fmol/mg, for the group of chronic hepatitis. It has been found that the number of binding sites of 3H-DHA significantly decreased and the number of binding sites of 3H-PRZ did not change in chronic hepatitis liver parenchyma in comparison with the control group. The results obtained suggest the important role of beta-adrenergic receptors in the pathogenesis of chronic hepatitis and in liver regeneration in children.
Kondratenko
T Ia
TIa
Kuzina
N V
NV
Zakharova
I V
IV
Leont'ev
A F
AF
Pashkevich
D D
DD
Seniakovich
V M
VM
Aleksandrov
A E
AE
Klochkov
S A
SA
D000293:Adolescent; D001665:Binding Sites; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D004082:Dihydroalprenolol / Q000378:metabolism; D006505:Hepatitis / Q000378:metabolism*; D006801:Humans; D008099:Liver / Q000737:chemistry*; D011224:Prazosin / Q000378:metabolism; D011869:Radioligand Assay; D011941:Receptors, Adrenergic / Q000032:analysis* / Q000378:metabolism; D011942:Receptors, Adrenergic, alpha / Q000032:analysis / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000032:analysis / Q000378:metabolism
D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D004082:Dihydroalprenolol; D011224:Prazosin
Izuchenie adrenergicheskikh retseptorov v parenkhime pecheni u deteĭ pri khronicheskom gepatite.